diet and lifestyle program for Liver Diseases
Phase-Based Progress Estimates
Effectiveness
Safety
Liver Diseases+3 More
diet and lifestyle program - BehavioralEligibility
18+
All Sexes
What conditions do you have?
Select
Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
This trial will test a very-low carbohydrate diet intervention for adults with Non-alcoholic Fatty Liver Disease.
Eligible Conditions
- Liver Diseases
- Fatty Liver, Non-alcoholic Fatty Liver Disease, NAFLD
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 2 Secondary · Reporting Duration: 4 months
4 months
Change in MRI-based liver fibrosis
Change in liver fat content using liver MRI-derived proton density fat fraction
Percent body weight change
Trial Safety
Safety Progress
Side Effects for
Complete Diet and Lifestyle Program
7%kidney stones
3%muscle cramping
3%blurry vision
Trial Design
1 Treatment Group
diet and lifestyle program
1 of 1
Experimental Treatment
40 Total Participants · 1 Treatment Group
Primary Treatment: diet and lifestyle program · No Placebo Group · Phase 1 & 2
diet and lifestyle program
Behavioral
Experimental Group · 1 Intervention: diet and lifestyle program · Intervention Types: BehavioralTreatment
First Studied
Drug Approval Stage
How many patients have taken this drug
diet and lifestyle program
2017
Completed Phase 2
~160
Trial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 4 months
Who is running the clinical trial?
National Institutes of Health (NIH)NIH
2,418 Previous Clinical Trials
24,557,527 Total Patients Enrolled
7 Trials studying Liver Diseases
316 Patients Enrolled for Liver Diseases
University of MichiganLead Sponsor
1,616 Previous Clinical Trials
6,330,829 Total Patients Enrolled
12 Trials studying Liver Diseases
599 Patients Enrolled for Liver Diseases
Eligibility Criteria
Age 18+ · All Participants · 7 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:You have regular access to the internet.\n
You have been approved by a physician to participate in this study.
You are able to attend in-person appointments in Ann Arbor.
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments